Home » Healthcare » UK Single-Use Bio-Processing Systems Market

UK Single-Use Bio-Processing Systems Market

UK Single-Use Bio-Processing Systems Market By Type (Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, Others); By Application (Research & Development, Manufacturing, Process Development, Commercial Production, Others); By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Academic & Research Institutes, Contract Manufacturing Organizations (CMOs), Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
UK Single-Use Bio-Processing Systems Market Size 2024	USD 716.29 million
UK Single-Use Bio-Processing Systems Market, CGR	16.12%
UK Single-Use Bio-Processing Systems Market Size 2032	USD 2,368.35 million

Market Overview

UK Single-Use Bio-Processing Systems market size was valued at USD 716.29 million in 2024 and is anticipated to reach USD 2,368.35 million by 2032, at a CAGR of 16.12% during the forecast period (2024-2032).

The UK single-use bio-processing systems market is driven by the growing demand for cost-effective and flexible biomanufacturing solutions, particularly in the pharmaceutical and biotechnology sectors. These systems offer significant advantages, such as reduced risk of cross-contamination, lower operational costs, and shorter production timelines, making them highly attractive for the development of biologics and vaccines. Additionally, the rising adoption of personalized medicine and biologic therapies further propels the need for scalable, efficient manufacturing methods. Market trends include increasing investments in research and development to enhance the capabilities of single-use technologies, as well as expanding applications across various stages of drug production. The growing focus on sustainability also supports market growth, with single-use systems reducing the need for cleaning and sterilization, thereby improving environmental efficiency. As biomanufacturing demands continue to evolve, single-use systems are becoming integral to advancing biopharmaceutical production.

The UK single-use bio-processing systems market is geographically diverse, with key hubs in London, Manchester, Birmingham, and Scotland. London leads as a major center for biopharmaceutical research and manufacturing, driven by a concentration of biotech companies and CDMOs. Manchester is emerging as a key player due to its strong life sciences sector, while Birmingham is growing in importance, particularly in vaccine production. Scotland, with its expanding biotech and therapeutic research, continues to gain traction in the market. Key players in the UK market include leading companies such as Sartorius AG, Merck KGaA, Eppendorf AG, Lonza Group AG, and Stedim Biotech, who provide a wide range of single-use bio-processing solutions. These companies are at the forefront of technological advancements and have a significant presence across various regions, contributing to the market’s growth through their innovative product offerings and strong regional infrastructure.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The UK single-use bio-processing systems market was valued at USD 716.29 million in 2024 and is projected to reach USD 2,368.35 million by 2032, growing at a CAGR of 16.12% from 2024 to 2032.

The global single-use bio-processing systems market was valued at USD 17,326.05 million in 2024 and is projected to reach USD 57,663.39 million by 2032, growing at a CAGR of 16.22% from 2024 to 2032.

Increasing demand for biologics, personalized medicine, and cost-effective biomanufacturing solutions drives market growth.
The adoption of flexible, scalable, and contamination-free production methods boosts market adoption.
Technological advancements, such as automation and digital integration, are enhancing operational efficiency.
Key players like Sartorius AG, Merck KGaA, and Eppendorf AG dominate the market, focusing on innovation and expanding product portfolios.
High upfront costs of single-use systems and environmental concerns related to disposable materials are limiting market growth.
London, Manchester, Birmingham, and Scotland are key regions driving market growth, with London holding the largest share due to its strong biopharma presence.

Report Scope

This report segments the UK Single-Use Bio-Processing Systems Market as follows:

Market Drivers

Increasing Demand for Biologics and Personalized Medicine

The growing demand for biologics, including monoclonal antibodies, gene therapies, and vaccines, is another key factor driving the UK single-use bio-processing systems market. As biologics continue to gain prominence in the treatment of chronic diseases, cancers, and rare conditions, biomanufacturers need more scalable and adaptable production methods. For instance, regulatory authorities such as the FDA and EMA impose stringent guidelines on biopharmaceutical manufacturing, encouraging the adoption of single-use technologies to ensure product safety and efficiency. Single-use systems provide a perfect solution for these needs due to their ability to streamline the manufacturing process and reduce turnaround times. Additionally, the rise in personalized medicine, which requires tailored drug formulations and smaller production batches, further accelerates the need for flexible, single-use bioprocessing technologies. These systems are well-suited to meet the demands of small, specialized batches while maintaining the quality and efficacy of the biologic products.

Advancements in Biomanufacturing Technology

Technological advancements in single-use bio-processing systems are contributing to their widespread adoption across the UK market. Innovations in materials, designs, and integration capabilities have made these systems more reliable, efficient, and capable of supporting complex production processes. For instance, the UK government has funded a £1.9 million project to develop sustainable materials for single-use bioprocessing equipment, aiming to enhance efficiency and reduce environmental impact. Developments in sensors, automation, and digital monitoring tools have enhanced the performance and control of single-use systems, making them more precise and scalable. These advancements not only improve the efficiency of the manufacturing process but also enhance product quality and regulatory compliance. As the biotechnology and pharmaceutical industries continue to evolve, the demand for cutting-edge, flexible manufacturing solutions increases, pushing the adoption of advanced single-use technologies.

Cost-Effectiveness and Operational Efficiency

One of the primary drivers for the growth of the UK single-use bio-processing systems market is their cost-effectiveness. Traditional bioprocessing systems require complex and costly cleaning, sterilization, and validation processes, which can increase operational expenses and production time. Single-use systems eliminate these requirements, leading to reduced capital expenditures and operational costs. With disposable components, these systems also lower maintenance and labor costs associated with cleaning and reusing equipment. As a result, single-use bio-processing solutions offer an efficient alternative for manufacturers, particularly for small-to-medium scale productions and contract manufacturers who face cost constraints. The ability to quickly set up and modify production lines also enhances operational flexibility, allowing companies to respond rapidly to changing market demands.

Environmental Sustainability and Regulatory Compliance

Environmental concerns and the drive for sustainability are becoming increasingly significant drivers of the single-use bio-processing market in the UK. Traditional bioprocessing systems require extensive cleaning and sterilization processes, which consume considerable amounts of water and chemicals. In contrast, single-use systems reduce these environmental burdens by eliminating the need for extensive cleaning procedures, thus lowering water and energy consumption. This shift aligns with the growing trend towards eco-friendly production methods and regulatory pressure for reduced environmental impact in industrial processes. Furthermore, single-use systems facilitate better regulatory compliance by ensuring consistent, contamination-free manufacturing, which is crucial in the highly regulated biopharmaceutical industry. As sustainability becomes a critical focus for the biomanufacturing sector, the demand for single-use bio-processing systems is expected to increase, driven by their environmental and compliance benefits.

Market Trends

Growing Adoption of Digital Integration and Automation

The integration of digital technologies and automation within single-use bio-processing systems is rapidly gaining momentum in the UK market. Advances in data analytics, artificial intelligence, and automation tools are enhancing the precision, efficiency, and control of biomanufacturing processes. For instance, the UK government’s digital transformation initiatives emphasize the importance of automation and AI in improving efficiency across industries, including biomanufacturing. Digital integration allows for real-time monitoring, predictive maintenance, and optimized performance of single-use systems. This trend reflects the broader move within the biotechnology and pharmaceutical industries toward smart manufacturing, where data-driven insights can improve product quality, reduce human error, and streamline operations. As digital tools continue to evolve, biomanufacturers are increasingly leveraging these technologies to enhance the effectiveness of single-use systems and drive higher levels of productivity.

Expansion into New Applications and Therapeutic Areas

Another key trend is the expansion of single-use bio-processing systems into new applications and therapeutic areas. While traditionally used in the production of monoclonal antibodies and vaccines, these systems are now being adapted for a broader range of biologic products, including gene therapies, cell therapies, and personalized medicines. For instance, the UK Medicines and Healthcare products Regulatory Agency (MHRA) has identified new opportunities to drive medical breakthroughs through clinical trials, highlighting the expansion of biologics and personalized medicine. As the biotechnology industry diversifies, single-use systems are proving to be a versatile solution for manufacturing various complex biologics. The flexibility of these systems supports the development of new treatments, such as cell-based therapies, which require unique production processes. This trend is being driven by the need for cost-effective, scalable, and contamination-free manufacturing solutions that can meet the evolving demands of the biopharmaceutical industry.

Shift Toward Modular and Scalable Systems

One of the prominent market trends in the UK single-use bio-processing systems industry is the increasing shift towards modular and scalable solutions. These systems allow biomanufacturers to quickly adapt their production lines to meet changing demands, making them ideal for the growing need for flexible and customizable manufacturing processes. Modular designs enable easy integration with existing facilities, reducing the need for extensive infrastructure upgrades. This trend is particularly relevant as the demand for personalized medicine and biologic therapies rises, as smaller and more specific production batches become increasingly common. By offering scalability, single-use systems support both small-scale clinical trials and large-scale commercial production, making them adaptable to different stages of product development.

Emphasis on Sustainability and Eco-Friendly Practices

Sustainability is a growing trend in the UK single-use bio-processing systems market, as environmental concerns continue to shape the industry. Single-use systems are seen as more environmentally friendly compared to traditional multi-use equipment due to their reduced water and chemical usage, as they do not require extensive cleaning between batches. Additionally, as the global focus on sustainability intensifies, there is an increasing push toward reducing waste and energy consumption in biomanufacturing processes. Many companies are now prioritizing eco-friendly practices by developing single-use systems made from recyclable and biodegradable materials. This trend reflects the biopharmaceutical industry’s broader commitment to reducing its environmental footprint while maintaining the efficiency and flexibility that single-use systems offer.

Market Challenges Analysis

High Upfront Costs and Investment

One of the primary challenges in the UK single-use bio-processing systems market is the high upfront costs associated with these systems. While they offer cost savings in terms of reduced operational expenses and the elimination of cleaning and sterilization procedures, the initial investment required for implementing single-use technologies can be significant. For smaller biomanufacturers or those with limited capital resources, these costs can be a barrier to adoption. Additionally, the costs of training staff, integrating new systems, and ensuring that the infrastructure is compatible with single-use technology further contribute to the financial burden. Despite the long-term cost advantages, this challenge can delay or limit the widespread adoption of single-use systems, especially among companies with constrained budgets or limited experience with advanced biomanufacturing technologies.

Concerns Over Environmental Impact of Disposable Materials

Although single-use bio-processing systems offer environmental benefits, such as reduced water and energy usage, concerns remain regarding the environmental impact of the disposable materials themselves. The widespread use of single-use plastics and other non-recyclable components in these systems has raised concerns about waste generation and landfill impact. For instance, the UK government has funded a £1.9 million project to develop sustainable materials for single-use bioprocessing equipment, aiming to enhance efficiency and reduce environmental impact. As demand for these systems increases, so does the volume of disposable waste, contributing to the global challenge of plastic pollution. While some manufacturers are focusing on developing recyclable and biodegradable materials, the industry still faces challenges in reducing the environmental footprint of disposable bio-processing components. Companies in the sector must balance the need for efficiency and cost-effectiveness with their responsibility to minimize environmental harm, which presents an ongoing challenge for the market.

Market Opportunities

The UK single-use bio-processing systems market presents significant opportunities for growth, particularly as the demand for biologics and personalized medicine continues to rise. With increasing investments in biopharmaceutical research and development, there is a growing need for scalable and flexible manufacturing solutions. Single-use systems offer biomanufacturers the ability to quickly adapt to changing production requirements, particularly for smaller and more specialized batches required for personalized treatments. As new therapies, including gene and cell-based therapies, gain traction, single-use systems are well-positioned to meet the specific production needs of these advanced treatments. The ability to scale operations efficiently while maintaining cost-effectiveness presents a compelling opportunity for manufacturers to expand their reach within emerging therapeutic areas, contributing to the overall market growth.

Furthermore, the increasing push for sustainable manufacturing processes presents another key opportunity for single-use bio-processing systems. With the biopharmaceutical industry under growing pressure to reduce its environmental impact, single-use technologies that minimize water usage, chemicals, and cleaning processes are becoming more attractive. Additionally, advancements in recyclable and biodegradable materials for single-use components provide manufacturers with opportunities to align their operations with broader sustainability goals. As regulatory bodies and consumers alike demand more eco-friendly solutions, single-use systems that emphasize environmental responsibility can gain a competitive edge. This trend aligns with the industry’s broader shift toward sustainable practices, making it a critical opportunity for companies looking to capitalize on both technological advancements and the increasing focus on environmental sustainability.

Market Segmentation Analysis:

By Type:

The UK single-use bio-processing systems market is segmented into several key product types, each playing a pivotal role in biomanufacturing processes. Single-use bioreactors are among the most important components, enabling efficient cell culture processes in the production of biologics, vaccines, and gene therapies. They are widely adopted for their scalability, flexibility, and reduced risk of contamination compared to traditional systems. Single-use mixers are another critical segment, used for mixing and blending various components during production. These systems ensure uniform mixing and prevent contamination, which is crucial in biologic production. Single-use bags are used for storage and transportation of biological products and materials, reducing the risk of contamination during handling. Single-use connectors facilitate the safe and reliable transfer of fluids between systems, maintaining the integrity of the bioprocess. Other components, such as filtration systems and sensors, further enhance the functionality and flexibility of single-use solutions. This segmentation highlights the diverse needs of the biomanufacturing industry, driven by the growing demand for flexible, scalable, and contamination-free solutions.

By Application:

The application segment of the UK single-use bio-processing systems market reflects the varied uses across different stages of biomanufacturing. In research and development, these systems offer flexibility and speed, enabling pharmaceutical companies to quickly scale up production for early-stage drug testing and clinical trials. As companies move toward manufacturing, single-use systems continue to offer cost-effective, scalable solutions that reduce setup times and contamination risks. In process development, these systems are essential for refining and optimizing bioprocesses before large-scale production begins. For commercial production, single-use technologies support high-volume manufacturing, ensuring compliance with industry standards while reducing operational costs. The “others” segment includes uses such as quality control and testing, which still benefit from single-use solutions for their convenience and efficiency. These segments underscore the broad applicability of single-use systems in the entire drug production lifecycle, from early-stage development to large-scale commercial manufacturing.

Segments:

Based on Type:

Single-Use Bioreactors
Single-Use Mixers
Single-Use Bags
Single-Use Connectors
Others

Based on Application:

Research & Development
Manufacturing
Process Development
Commercial Production
Others

Based on End- User:

Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Contract Manufacturing Organizations (CMOs)
Others

Based on the Geography:

London
Manchester
Birmingham
Scotland

Regional Analysis

London

London holds the largest market share, accounting for approximately 40% of the UK market. This dominance is primarily due to the concentration of leading pharmaceutical and biotechnology companies in the capital. London serves as the hub for cutting-edge biopharmaceutical research, development, and manufacturing. The presence of numerous contract development and manufacturing organizations (CDMOs), coupled with extensive investment in biomanufacturing infrastructure, strengthens its position as the market leader. As the demand for biologics, personalized medicine, and gene therapies grows, London’s advanced healthcare ecosystem continues to drive significant adoption of single-use bio-processing technologies.

Manchester

Manchester, with a market share of around 20%, stands as a growing player in the UK’s biomanufacturing landscape. Known for its strong research institutions and biotech startups, Manchester is quickly becoming a hub for biopharmaceutical innovation. The city benefits from substantial investments in life sciences, particularly in regenerative medicine and cell therapies, driving the demand for flexible and scalable manufacturing solutions. Moreover, Manchester’s strategic location in the north of England provides access to a wide network of suppliers and manufacturers, enhancing its appeal for the implementation of single-use technologies. As the city continues to develop its biomanufacturing capabilities, its share of the market is expected to expand further.

Birmingham

Birmingham, contributing approximately 15% to the market, is another key region for the adoption of single-use bio-processing systems in the UK. As the second-largest city in the country, Birmingham’s life sciences sector is thriving, with significant growth in biopharmaceutical and vaccine production. The region’s focus on biomanufacturing innovation, supported by the University of Birmingham and local industry partnerships, creates strong demand for advanced technologies such as single-use systems. Additionally, the city’s central location and transport links make it a strategic site for large-scale production facilities, attracting more biopharmaceutical companies and boosting the use of flexible production methods like single-use technologies.

Scotland

Scotland, with a market share of around 10%, has established itself as a prominent region for biotechnological advancements, particularly in the fields of diagnostics, vaccines, and gene therapies. Edinburgh and Glasgow are central to Scotland’s life sciences industry, with a growing number of biotech startups and established research organizations focusing on novel therapeutics. Scotland’s adoption of single-use bio-processing systems is increasingly driven by the demand for efficient and scalable manufacturing solutions, especially for the growing biotech sector. The Scottish government’s strong support for innovation and biomanufacturing infrastructure further fosters the uptake of single-use systems. While its market share is smaller compared to London and Manchester, Scotland’s biomanufacturing sector is on a positive growth trajectory, signaling potential for greater market penetration in the coming years.

Key Player Analysis

Sartorius AG
Merck KGaA
Eppendorf AG
Celltainer Biotech BV
Lonza Group AG
Getinge AB
RoSS GmbH
Elveflow
Finesse Solutions
Stedim Biotech

Competitive Analysis

The UK single-use bio-processing systems market is highly competitive, with several leading players offering advanced solutions to meet the growing demand for efficient and flexible biomanufacturing technologies. Key players in this market include Sartorius AG, Merck KGaA, Eppendorf AG, Celltainer Biotech BV, Lonza Group AG, Getinge AB, RoSS GmbH, Elveflow, Finesse Solutions, and Stedim Biotech. These companies are continuously investing in research and development to enhance their product offerings and strengthen their market positions. Leading companies are focusing on innovation, expanding product portfolios, and investing heavily in research and development to improve the efficiency and scalability of their offerings. These companies compete on the basis of technological advancements, such as the integration of automation, digital monitoring systems, and flexible production capabilities. Additionally, strategic partnerships and collaborations with pharmaceutical and biotech companies play a significant role in enhancing market presence. Smaller companies are also carving out niches in specialized bio-processing components, while larger companies are leveraging their global distribution networks to gain market share. Competitive dynamics are further shaped by the increasing demand for sustainable and eco-friendly solutions, prompting companies to innovate with recyclable or biodegradable materials. Despite the strong competition, the need for efficient, contamination-free, and flexible production methods ensures that the market continues to grow, driving companies to differentiate themselves with superior technologies, scalability, and cost-effectiveness.

Recent Developments

In April 2025, Thermo Fisher Scientific launched the 5L DynaDrive Single-Use Bioreactor, a bench-scale system designed for seamless scalability from 1 to 5,000 liters. This new bioreactor offers a 27% productivity increase over glass bioreactors, enhanced sustainability with biobased films, and consistent performance across different scales, supporting both large and small biopharma manufacturers. The DynaDrive S.U.B. supports robust production across scales and has the flexibility to accommodate a variety of cell lines and processing modalities.
In April 2025, Sartorius Stedim Biotech entered a strategic partnership with Tulip Interfaces to drive digital transformation in single-use bioprocessing. The collaboration introduced Biobrain® Operate powered by Tulip, a suite of digital manufacturing applications that integrate with Sartorius equipment to reduce process variability, digitize operations, and ensure regulatory compliance. This partnership aims to advance paperless manufacturing and optimize resource efficiency in bioprocessing.
In March 2025, Corning introduced new technologies to support advanced therapy applications, including the Ascent™ Fixed Bed Reactor (FBR) and expanded cell expansion platforms like HYPERStack®, HYPERFlask®, and CellSTACK®. These platforms feature closed systems and automation to reduce contamination risk and enhance scalability for bioprocess applications.
In April 2023, Merck KGaA launched the Ultimus® Single-Use Process Container Film, featuring ten times greater abrasion resistance than other films, improved durability, and leak resistance for single-use assemblies. The technology is now available in Mobius® 3D process containers, enhancing operational efficiency and cell growth performance.

Market Concentration & Characteristics

The UK single-use bio-processing systems market exhibits moderate concentration, with a mix of large multinational companies and specialized regional players dominating the landscape. Leading companies hold significant market share due to their extensive product portfolios, technological innovations, and established relationships with key stakeholders in the pharmaceutical and biotechnology sectors. These larger players often have strong global networks and considerable financial resources, enabling them to invest heavily in research and development, as well as to expand their manufacturing capabilities. On the other hand, smaller, specialized companies cater to niche applications and focus on offering highly customizable solutions. The market is characterized by rapid innovation, particularly in areas such as automation, digital integration, and eco-friendly alternatives. Competitive dynamics are influenced by factors such as product differentiation, scalability, cost-effectiveness, and sustainability. As demand for biologics and personalized medicine grows, companies are adapting to changing industry needs and striving to maintain a competitive edge.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The UK single-use bio-processing systems market is expected to grow due to increasing demand for biologics and personalized medicine.
Technological advancements in disposable bioreactors and filtration systems will improve process efficiency and reduce contamination risks.
There will be a continued shift towards automation and digitalization in the bio-processing industry to enhance productivity and monitoring.
The development of next-generation single-use technologies will offer more scalable and flexible production options for drug manufacturers.
Regulatory bodies will likely implement stricter standards for single-use systems to ensure product safety and compliance.
Increased focus on sustainability will drive the adoption of eco-friendly, recyclable, and energy-efficient single-use solutions.
Partnerships between biotech companies and single-use system manufacturers will strengthen the integration of these systems into commercial production.
The demand for personalized medicine will fuel the need for more flexible and cost-effective bio-processing technologies.
Single-use systems will become more cost-effective due to improvements in design and the economy of scale, making them accessible to smaller companies.
The UK’s regulatory environment will support innovation, fostering a competitive market for single-use bio-processing systems and attracting global investments.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Single-Use Bio-Processing Systems Market Snapshot 21

2.1.1. UK Single-Use Bio-Processing Systems Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Growing Adoption of Disposable Technologies in Biopharmaceutical Manufacturing 25

4.2.2. Increasing Demand for Cost-Effective and Scalable Bioprocessing Solutions 26

4.3. Market Restraints 27

4.3.1. Concerns Related to Leachables and Extractables in Single-Use Systems 27

4.4. Market Opportunities 28

4.4.1. Advancements in Bioprocessing Technology Driving Innovation in Single-Use Systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by UK 31

5.1.1. UK Single-Use Bio-Processing Systems Market Import Volume/Revenue, By UK, 2018 – 2023 31

5.2. Export Analysis by UK 32

5.2.1. UK Single-Use Bio-Processing Systems Market Export Volume/Revenue, By UK, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by UK 33

6.1.1. UK Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By UK, 2018 – 2023 33

6.2. Supply Analysis by UK 34

6.2.1. UK Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By UK, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by UK 35

7.1.1. UK Single-Use Bio-Processing Systems Market Production Volume/Revenue, By UK, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. UK Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

8.1.2. UK Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. UK Single-Use Bio-Processing Systems Market: Company Market Share, by Volume, 2023 40

11.2.2. UK Single-Use Bio-Processing Systems Market: Company Market Share, by Revenue, 2023 41

11.2.3. UK Single-Use Bio-Processing Systems Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. UK Single-Use Bio-Processing Systems Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. UK Single-Use Bio-Processing Systems Market Company Volume Market Share, 2023 43

11.4. UK Single-Use Bio-Processing Systems Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

UK Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Single-Use Bio-Processing Systems Market Overview, by Type Segment 49

13.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Single-Use Bioreactors 53

13.3. Single-Use Mixers 54

13.4. Single-Use Bags 55

13.5. Single-Use Connectors 56

13.6. Others 57

CHAPTER NO. 14 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. Single-Use Bio-Processing Systems Market Overview, by Application Segment 58

14.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Research & Development 62

14.3. Manufacturing 63

14.4. Process Development 64

14.5. Commercial Production 65

14.6. Others 66

CHAPTER NO. 15 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY END-USER SEGMENT ANALYSIS 67

15.1. Single-Use Bio-Processing Systems Market Overview, by End-user Segment 67

15.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

15.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By End-user 69

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 69

15.1.4. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

15.2. Pharmaceutical & Biotechnology Companies 71

15.3. Contract Research Organizations (CROs) 72

15.4. Academic & Research Institutes 73

15.5. Contract Manufacturing Organizations (CMOs) 74

15.6. Others 75

CHAPTER NO. 16 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – UK ANALYSIS 76

16.1. Type 76

16.1.1. UK Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

16.2. UK Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

16.3. Application 77

16.3.1. UK Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

16.3.2. UK Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

16.4. End-user 78

16.4.1. UK Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

16.4.2. UK Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

CHAPTER NO. 17 : COMPANY PROFILES 79

17.1. Sartorius AG 79

17.1.1. Company Overview 79

17.1.2. Product Portfolio 79

17.1.3. Swot Analysis 79

17.1.4. Business Strategy 80

17.1.5. Financial Overview 80

17.2. Merck KGaA 81

17.3. Eppendorf AG 81

17.4. Celltainer Biotech BV 81

17.5. Lonza Group AG 81

17.6. Getinge AB 81

17.7. RoSS GmbH 81

17.8. Elveflow 81

17.9. Finesse Solutions 81

17.10. Stedim Biotech 81

List of Figures

FIG NO. 1. UK Single-Use Bio-Processing Systems Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for UK Single-Use Bio-Processing Systems Market 29

FIG NO. 3. UK Single-Use Bio-Processing Systems Market Import Volume/Revenue, By UK, 2018 – 2023 31

FIG NO. 4. UK Single-Use Bio-Processing Systems Market Export Volume/Revenue, By UK, 2018 – 2023 32

FIG NO. 5. UK Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By UK, 2018 – 2023 33

FIG NO. 6. UK Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By UK, 2018 – 2023 34

FIG NO. 7. UK Single-Use Bio-Processing Systems Market Production Volume/Revenue, By UK, 2018 – 2023 35

FIG NO. 8. UK Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for UK Single-Use Bio-Processing Systems Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Single-Use Bio-Processing Systems Market – Company Volume Market Share, 2023 43

FIG NO. 18. Single-Use Bio-Processing Systems Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. UK Single-Use Bio-Processing Systems Market for Single-Use Bioreactors, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. UK Single-Use Bio-Processing Systems Market for Single-Use Mixers, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. UK Single-Use Bio-Processing Systems Market for Single-Use Bags, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. UK Single-Use Bio-Processing Systems Market for Single-Use Connectors, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. UK Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. UK Single-Use Bio-Processing Systems Market for Research & Development, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. UK Single-Use Bio-Processing Systems Market for Manufacturing, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. UK Single-Use Bio-Processing Systems Market for Process Development, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. UK Single-Use Bio-Processing Systems Market for Commercial Production, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. UK Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. UK Single-Use Bio-Processing Systems Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. UK Single-Use Bio-Processing Systems Market for Contract Research Organizations (CROs), Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. UK Single-Use Bio-Processing Systems Market for Academic & Research Institutes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. UK Single-Use Bio-Processing Systems Market for Contract Manufacturing Organizations (CMOs), Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. UK Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 75

List of Tables

TABLE NO. 1. : UK Single-Use Bio-Processing Systems Market: Snapshot 21

TABLE NO. 2. : Drivers for the Single-Use Bio-Processing Systems Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Single-Use Bio-Processing Systems Market: Impact Analysis 27

TABLE NO. 4. : UK Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : UK Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

TABLE NO. 7. : UK Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

TABLE NO. 8. : UK Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

TABLE NO. 9. : UK Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

TABLE NO. 10. : UK Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

TABLE NO. 11. : UK Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

Frequently Asked Questions

What is the current size of the UK Single-Use Bio-Processing Systems?

The UK Single-Use Bio-Processing Systems market was valued at USD 716.29 million in 2024 and is projected to reach USD 2,368.35 million by 2032.

What factors are driving the growth of the UK Single-Use Bio-Processing Systems?

Growth is driven by rising demand for biologics, personalized medicine, and cost-effective, scalable biomanufacturing solutions.

What are some challenges faced by the UK Single-Use Bio-Processing Systems?

High upfront costs and environmental concerns related to disposable plastic components pose key challenges.

Who are the major players in the UK Single-Use Bio-Processing Systems?

Major players include Sartorius AG, Merck KGaA, Eppendorf AG, Lonza Group AG, and Stedim Biotech.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –